HK1131054A1 - Use of tenecteplase for treating acute ischemic stroke - Google Patents

Use of tenecteplase for treating acute ischemic stroke

Info

Publication number
HK1131054A1
HK1131054A1 HK09110542.3A HK09110542A HK1131054A1 HK 1131054 A1 HK1131054 A1 HK 1131054A1 HK 09110542 A HK09110542 A HK 09110542A HK 1131054 A1 HK1131054 A1 HK 1131054A1
Authority
HK
Hong Kong
Prior art keywords
tenecteplase
ischemic stroke
treating acute
acute ischemic
treating
Prior art date
Application number
HK09110542.3A
Other languages
English (en)
Chinese (zh)
Inventor
Peter Kuebler
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38835003&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1131054(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of HK1131054A1 publication Critical patent/HK1131054A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/49—Urokinase; Tissue plasminogen activator
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dermatology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Enzymes And Modification Thereof (AREA)
HK09110542.3A 2006-08-29 2009-11-12 Use of tenecteplase for treating acute ischemic stroke HK1131054A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US82386806P 2006-08-29 2006-08-29
PCT/US2007/074997 WO2008027687A2 (en) 2006-08-29 2007-08-01 Use of tenecteplase for treating acute ischemic stroke

Publications (1)

Publication Number Publication Date
HK1131054A1 true HK1131054A1 (en) 2010-01-15

Family

ID=38835003

Family Applications (1)

Application Number Title Priority Date Filing Date
HK09110542.3A HK1131054A1 (en) 2006-08-29 2009-11-12 Use of tenecteplase for treating acute ischemic stroke

Country Status (22)

Country Link
US (2) US20080107641A1 (xx)
EP (1) EP2056856B1 (xx)
JP (1) JP5785687B2 (xx)
KR (1) KR20090045405A (xx)
CN (1) CN101505785A (xx)
AU (1) AU2007290277B2 (xx)
BR (1) BRPI0716143A2 (xx)
CA (1) CA2661012C (xx)
CO (1) CO6150188A2 (xx)
EA (1) EA015573B1 (xx)
EC (1) ECSP099178A (xx)
HK (1) HK1131054A1 (xx)
IL (2) IL196987A (xx)
MX (1) MX2009001918A (xx)
MY (1) MY163119A (xx)
NO (1) NO342302B1 (xx)
NZ (1) NZ574767A (xx)
SG (3) SG174753A1 (xx)
TW (1) TWI439282B (xx)
UA (1) UA97486C2 (xx)
WO (1) WO2008027687A2 (xx)
ZA (1) ZA200900957B (xx)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7759506B2 (en) 2002-02-25 2010-07-20 Diffusion Pharmaceuticals Llc Bipolar trans carotenoid salts and their uses
EP2540696B1 (en) 2005-02-24 2020-01-01 Diffusion Pharmaceuticals LLC Trans carotenoids, formulation and uses
AU2007290277B2 (en) 2006-08-29 2013-04-11 Genentech, Inc. Use of tenecteplase for treating acute ischemic stroke
KR101570131B1 (ko) 2007-04-13 2015-11-18 디퓨젼 파마슈티컬즈 엘엘씨 양극성 트랜스 카로티노이드의 말초혈관질환 치료와 예방을 위한 용도
US9034007B2 (en) 2007-09-21 2015-05-19 Insera Therapeutics, Inc. Distal embolic protection devices with a variable thickness microguidewire and methods for their use
US20110257510A1 (en) * 2008-12-24 2011-10-20 Koninklijke Philips Electronics N.V. System, method and apparatus for cardiac intervention with mr stroke detection and treatment
EP2445339B1 (en) 2009-06-22 2019-08-07 Diffusion Pharmaceuticals LLC Diffusion enhancing compound and its use with a thrombolytic
US10555915B2 (en) 2009-08-24 2020-02-11 Hough Ear Institute Methods for treating acute acoustic trauma
CN105287473A (zh) 2010-06-02 2016-02-03 扩散药品有限公司 包含双极性反式类胡萝卜素的组合物及其应用
BR112013015914B1 (pt) * 2010-12-23 2021-06-08 Gennova Biopharmaceuticals Ltd. composições farmacêuticas de tenecteplase
WO2014062888A1 (en) * 2012-10-18 2014-04-24 University Of South Florida Compositions and methods for treating stroke
US8679150B1 (en) 2013-03-15 2014-03-25 Insera Therapeutics, Inc. Shape-set textile structure based mechanical thrombectomy methods
US8715315B1 (en) 2013-03-15 2014-05-06 Insera Therapeutics, Inc. Vascular treatment systems
US8715314B1 (en) 2013-03-15 2014-05-06 Insera Therapeutics, Inc. Vascular treatment measurement methods
CN109730806B (zh) 2013-03-15 2023-01-24 伊瑟拉医疗公司 脉管治疗装置和方法
WO2015023830A1 (en) 2013-08-14 2015-02-19 Stc.Unm Treatment and prevention of stroke and other neurological disorders
ES2829923T3 (es) * 2014-10-21 2021-06-02 Gennova Biopharmaceuticals Ltd Un proceso novedoso de purificación para el aislamiento y la producción comercial de tnk-tpa recombinante (tenecteplase)
CN108697423A (zh) 2016-02-16 2018-10-23 伊瑟拉医疗公司 抽吸装置和锚定的分流装置
WO2017165667A1 (en) 2016-03-24 2017-09-28 Diffusion Pharmaceuticals Llc Use of bipolar trans carotenoids with chemotherapy and radiotherapy for treatment of cancer
CA3050858A1 (en) * 2017-01-24 2018-08-02 Ekos Corporation Method for the treatment of thromboembolism
WO2018210860A1 (en) * 2017-05-16 2018-11-22 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and pharmaceutical compositions for the treatment of acute ischemic stroke
US10426424B2 (en) 2017-11-21 2019-10-01 General Electric Company System and method for generating and performing imaging protocol simulations
WO2021158799A1 (en) * 2020-02-04 2021-08-12 The Regents Of The University Of Colorado, A Body Corporate Prophylactic uses of annexin a2

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4485045A (en) 1981-07-06 1984-11-27 Research Corporation Synthetic phosphatidyl cholines useful in forming liposomes
US4544545A (en) 1983-06-20 1985-10-01 Trustees University Of Massachusetts Liposomes containing modified cholesterol for organ targeting
US5013556A (en) 1989-10-20 1991-05-07 Liposome Technology, Inc. Liposomes with enhanced circulation time
AU664469B2 (en) 1992-06-03 1995-11-16 Genentech Inc. Tissue plasminogen activator glycosylation variants with improved therapeutic properties
JP2002173447A (ja) * 2000-09-29 2002-06-21 Yamanouchi Pharmaceut Co Ltd 脳塞栓症治療用医薬組成物
US7084118B2 (en) * 2002-02-22 2006-08-01 Genentech, Inc. Combination treatment with t-PA variant and low molecular weight heparin
US20030180282A1 (en) * 2002-03-25 2003-09-25 Victor Serebruany Method of treatment of thrombotic events
US20070014779A1 (en) * 2002-11-14 2007-01-18 Genentech, Inc. Plasminogen activator variant formulations
WO2006094120A2 (en) * 2005-03-02 2006-09-08 The Regents Of The University Of California Treatment for embolic stroke
AU2007290277B2 (en) 2006-08-29 2013-04-11 Genentech, Inc. Use of tenecteplase for treating acute ischemic stroke

Also Published As

Publication number Publication date
SG10201501498VA (en) 2015-04-29
JP2010502629A (ja) 2010-01-28
IL196987A0 (en) 2011-08-01
NO342302B1 (no) 2018-04-30
WO2008027687A3 (en) 2008-05-22
ZA200900957B (en) 2010-05-26
EA015573B1 (ru) 2011-10-31
MX2009001918A (es) 2009-03-06
UA97486C2 (ru) 2012-02-27
NZ574767A (en) 2012-02-24
ECSP099178A (es) 2009-06-30
IL196987A (en) 2016-10-31
US20120164157A1 (en) 2012-06-28
SG174753A1 (en) 2011-10-28
JP5785687B2 (ja) 2015-09-30
TW200817033A (en) 2008-04-16
TWI439282B (zh) 2014-06-01
AU2007290277A1 (en) 2008-03-06
KR20090045405A (ko) 2009-05-07
US20080107641A1 (en) 2008-05-08
US9023346B2 (en) 2015-05-05
EA200970237A1 (ru) 2009-08-28
IL248176A0 (en) 2016-11-30
AU2007290277B2 (en) 2013-04-11
NO20091296L (no) 2009-05-28
CA2661012C (en) 2019-03-19
CA2661012A1 (en) 2008-03-06
EP2056856A2 (en) 2009-05-13
CO6150188A2 (es) 2010-04-20
SG10201804944XA (en) 2018-07-30
WO2008027687A2 (en) 2008-03-06
EP2056856B1 (en) 2015-01-14
BRPI0716143A2 (pt) 2013-11-26
CN101505785A (zh) 2009-08-12
MY163119A (en) 2017-08-15

Similar Documents

Publication Publication Date Title
SG10201501498VA (en) Use of tenecteplase for treating acute ischemic stroke
IL194113A (en) Combinations of stroke treatment materials
EP2034830A4 (en) PROCESS FOR TREATMENT OF STROKE
IL193460A0 (en) Compounds and methods for treatment of stroke
EP2330302A4 (en) CYLINDER APPARATUS
ZA201004859B (en) Use of a gamma-secretase inhibitor for treating cancer
EP1996182A4 (en) CANCER TREATMENT WITH GAMMA SECRETASE INHIBITORS
IL193639A0 (en) Collagenase for treating cellulite
EP2264308A4 (en) PLASMA DEVICE WITH CYLINDER HEAD
EP2047976A4 (en) STEEL PLATE REINFORCING MATERIAL OF ANY KIND WHICH GIVES VIBRATION DAMPING PERFORMANCE TO A STEEL PLATE
EP2325529A4 (en) ZYLINDERKOPFDICHTUNG
EP2078522A4 (en) COMPOSITION FOR THE TREATMENT OF ALLERGIES
GB2457583B (en) Paint-metering cylinder
GB0815766D0 (en) Rotary piston and cylinder devices
EP2131030A4 (en) CYLINDER BLOCK
IL212212A0 (en) Compound useful for treating cellulite
EP2249765A4 (en) DAPSONE TO TREAT THE ROSACEA
GB2453625B (en) Keys for cylinder assemblies
ZA200807221B (en) Collagenase for treating cellulite
EP2306051A4 (en) CYLINDER SEAL
HK1119755A1 (en) Brake cylinder
IL201328A0 (en) Cylinder lock
TWI368170B (en) Interruption-based concurrent profiling method
GB0817784D0 (en) Hydraulic cylinder and related arrangements
GB2453626B (en) Keys for cylinder assemblies